Daniel P. Nussbaum
General Surgery | Surgical Oncology
20 Duke Medicine Cir
Durham, NC 27710
Durham, NC 27710
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
ASO Visual Abstract: Inpatient Palliative Care and Procedural Intensity in Patients with Hepatopancreatobiliary Cancers at the End of Life.
Journal: Annals of surgical oncology
Published: July 25, 2026
Hierarchical classification of immune cell transcriptomes at population-scale.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Hierarchical classification of immune cell transcriptomes at population-scale.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Assessing PANACHE's Style and Substance for Deep Learning Prognostication in Pancreatic Cancer.
Journal: JCO clinical cancer informatics
Published: April 29, 2026
Inpatient Palliative Care and Procedural Intensity in Patients with Hepatopancreatobiliary Cancers at the End of Life.
Journal: Annals of surgical oncology
Published: April 06, 2026
The GENIE Data Model: A Solid Tumor, Person-Centric Framework for Scalable, Harmonized Precision Oncology Data Collection.
Journal: Cancer research communications
Published: February 24, 2026
Prognostic Implications of Codon-Specific KRAS Mutations in Localized and Advanced Stages of Pancreatic Cancer.
Journal: JCO precision oncology
Published: February 19, 2026
Preparing for the Inevitable: Early Comprehensive Genomic Profiling for Patients With Localized Pancreatic Ductal Adenocarcinoma.
Journal: JCO oncology practice
Published: November 14, 2025
Comparing traditional versus total neoadjuvant chemotherapy for patients with localized pancreatic cancer.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: October 23, 2025
Physician Perspectives on ChatGPT-4o as a Patient Resource for Abdominal Cancer Surgeries: Cross-Sectional Survey.
Journal: JMIR perioperative medicine
Published: July 27, 2025
SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multicenter, Retrospective Cohort Study.
Journal: Annals of surgery
Published: June 05, 2025
A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution.
Journal: Cancer immunology, immunotherapy : CII
Published: June 03, 2025
Last Updated: 09/26/2026